A prospective, non-inferiority, randomised controlled TCW trial at 18 tertiary centres (2018-2023). Patients (n = 172) had severe aortic stenosis and complex coronary artery disease. They were ...
Minimally invasive valve replacement is reducing recovery times, lowering surgical risks, and expanding eligibility to intermediate- and low-risk patients. Hospitals, payers, and device manufacturers ...
ST. JOSEPH COUNTY, Ind. (WSBT) — The options for cardiovascular procedures have expanded over the last decade. Among options for patients with aortic stenosis - a minimally invasive procedure known as ...
- Transcatheter aortic valve replacement (TAVR) procedure treats people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery - With Portico approval, Abbott ...
In the United States, cardiovascular health is especially important. Heart disease is the leading cause of death in the U.S., and as many as 1.5 million people have been diagnosed with aortic stenosis ...
Expected FDA approval of transcatheter aortic valve replacement devices, already approved in Europe, would set off a boom in such devices over the next few years, according to a news release by the ...
Transcatheter aortic valve replacement (TAVR) demonstrated better short-term outcomes, while surgical aortic valve replacement (SAVR) had better long-term outcomes. A recent study found that when it ...
ELKHART, Ind. (WSBT) — Al Cover is walking and exercising again the way he was a few years ago. “I'm back to where I was before, doing hills. And in my work, my partners recognize the increase in my ...
Rising prevalence of valvular heart diseases, expanding elderly population, and growing preference for minimally invasive cardiac procedures are driving the transcatheter heart valve replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback